Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Thorax
CLINICAL
Respiratory medicine
Interstitial lung disease
Email alerts
Interstitial lung disease
P39 CTAS – a ct score to quantify disease activity in pulmonary sarcoidosis
YK
Kendrick
,
E
Repapi
,
E
Helm
,
SL
Cole
,
R
Hoyles
,
R
Benamore
,
LP
Ho
Thorax
Dec 2016,
71
(Suppl 3)
A103;
DOI:
10.1136/thoraxjnl-2016-209333.182
P40 Development of 18f and 68ga-labelled cyclic peptides for positron emission tomography imaging of αvβ6 in idiopathic pulmonary fibrosis
JA
Thompson
,
J
Domarkas
,
C
Cawthorne
,
SJ
Archibald
,
S
Hart
Thorax
Dec 2016,
71
(Suppl 3)
A103-A104;
DOI:
10.1136/thoraxjnl-2016-209333.183
P41 A prospective cohort study to measure in-vivo changes in lung glucose metabolism in patients with sscl-ild using fdg-pet
HS
Garthwaite
,
V
Holmes
,
T
Mikolasch
,
G
Azzopardi
,
CP
Denton
,
AM
Groves
,
JC
Porter
Thorax
Dec 2016,
71
(Suppl 3)
A104;
DOI:
10.1136/thoraxjnl-2016-209333.184
P42 Increased FDG uptake in areas of ‘normal’ lung in idiopathic pulmonary fibrosis
SA
Aliyu
,
G
Avery
,
AH
Morice
,
SP
Hart
,
MG
Crooks
Thorax
Dec 2016,
71
(Suppl 3)
A104-A105;
DOI:
10.1136/thoraxjnl-2016-209333.185
S97 Annual rate of fvc decline in various patient sub-groups with idiopathic pulmonary fibrosis treated with pirfenidone: pooled analysis from 3 pivotal studies
PW
Noble
,
C
Albera
,
W
Chou
,
U
Costabel
,
B
Day
,
I
Glaspole
,
MK
Glassberg
,
L
Lancaster
,
DJ
Lederer
,
SD
Nathan
,
CA
Pereira
,
J
Stauffer
,
JJ
Swigris
Thorax
Dec 2016,
71
(Suppl 3)
A57;
DOI:
10.1136/thoraxjnl-2016-209333.103
S98 Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatment
M
Kreuter
,
P
Spagnolo
,
W
Wuyts
,
E
Renzoni
,
D
Koschel
,
F
Bonella
,
TM
Maher
,
M
Kolb
,
D
Weycker
,
K
Kirchgässler
,
U
Costabel
Thorax
Dec 2016,
71
(Suppl 3)
A58;
DOI:
10.1136/thoraxjnl-2016-209333.104
S99 Efficacy of nintedanib on acute exacerbations reported as serious adverse events in the inpulsis® trials in idiopathic pulmonary fibrosis (IPF)
L
Richeldi
,
H
Koegler
,
M
Trampisch
,
S
Geier
,
M
Kreuter
Thorax
Dec 2016,
71
(Suppl 3)
A58-A59;
DOI:
10.1136/thoraxjnl-2016-209333.105
S100 Cumulative distribution of patients by change in FVC% predicted in the inpulsis® trials of NINTEDANIB in patients with idiopathic pulmonary fibrosis
U
Costabel
,
KR
Flaherty
,
KK
Brown
,
W
Stansen
,
R
Schlenker-Herceg
,
G
Raghu
Thorax
Dec 2016,
71
(Suppl 3)
A59;
DOI:
10.1136/thoraxjnl-2016-209333.106
S101 Single centre experience of switching patients with idiopathic pulmonary fibrosis from pirfenidone to nintedanib
A
Rathnapala
,
A
Fries
,
C
Ruggiero
,
LP
Ho
,
RK
Hoyles
Thorax
Dec 2016,
71
(Suppl 3)
A60;
DOI:
10.1136/thoraxjnl-2016-209333.107
S134 How specific are fluorogenic substrates designed to analyse active protease biomarkers of respiratory disease?
CM
Robb
,
TEG
Ferguson
,
KL
Moffitt
,
DG
Downey
,
DF
McCafferty
,
D
Ribeiro
,
SL
Martin
,
B
Walker
Thorax
Dec 2016,
71
(Suppl 3)
A79-A80;
DOI:
10.1136/thoraxjnl-2016-209333.140
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
CLINICAL
Cardiovascular medicine
Heart failure
(32)
Ischaemic heart disease
(138)
Venous thromboembolism
(180)
Diagnostics
Radiology (diagnostics)
(980)
Ear, nose and throat/otolaryngology
(245)
Emergency medicine
(215)
Evidence based practice
Changing physician behavior
Clinical decision making
Clinical prediction rules
Effectiveness of care
Getting research into practice
General practice / family medicine
(369)
Genetics
Clinical genetics
(32)
Cytogenetics
(2)
Genetic screening / counselling
(97)
Molecular genetics
(227)
Geriatric medicine
End of life decisions (geriatric medicine)
(32)
Long term care
(6)
Infectious diseases
Drugs: infectious diseases
(1110)
Emerging infectious diseases
Bird flu
(15)
HIV/AIDS
(224)
Influenza
(119)
Nosocomial infections
(1)
Pneumonia (infectious disease)
(672)
TB and other respiratory infections
(1448)
Tropical medicine (infectious diseases)
(30)
Vaccination / immunisation
(178)
Intensive care
Adult intensive care
(193)
Mechanical ventilation
(173)
Paediatric intensive care
(1)
Neurology
Muscle disease
(38)
Neuromuscular disease
(94)
Sleep disorders (neurology)
(212)
Nursing
(18)
Oncology
Chemotherapy
(209)
Lung cancer (oncology)
(752)
Respiratory cancer
(118)
Screening (oncology)
(488)
Paediatrics
Child health
(943)
Infant health
(57)
Neonatal health
(40)
Palliative care
End of life decisions (palliative care)
(32)
Hospice
(92)
Pain (palliative care)
Pathology
Chemical pathology
Cytopathology
(4)
Histopathology
(37)
Immunohistochemistry
Infection (pathology)
Inflammation
(1149)
Microbiology
Microscopy
Molecular biology
(3)
Morbid anatomy / surgical pathology
(8)
Virology
Pharmacology and therapeutics
Drug misuse (including addiction)
Medicines regulation
(25)
Toxicology
Unwanted effects / adverse reactions
(32)
Pharmacology and therapeutics
Rehabilitation medicine
Disability
(12)
Respiratory medicine
Adult respiratory distress syndrome
(123)
Airway biology
(1200)
Asthma
(1961)
Bronchiolitis
(124)
Bronchitis
(257)
Bronchopulmonary dysplasia
(23)
Congenital cystic adenomatoid malformation of lung
(1)
Cystic fibrosis
(598)
Drugs: respiratory system
(581)
Fungal lung diseases
(59)
Hemoptysis
(111)
Interstitial lung disease
(638)
Lung abscess
(6)
Lung cancer (respiratory medicine)
(752)
Lung function
(836)
Lung haemorrhage
Lung infection
(113)
Lung neoplasms
(684)
Mechanical ventilation
(190)
Meconium aspiration
(1)
Parasitic lung disease
(2)
Pneumonia (respiratory medicine)
(650)
Pulmonary alveolar proteinosis
(14)
Pulmonary embolism
(160)
Pulmonary emphysema
(27)
Pulmonary endometriosis
Pulmonary eosinophilia
(17)
Pulmonary hypertension
(226)
Pulmonary oedema
(35)
Pulmonary plasma cell granuloma
Pulmonary veno-occulsive disease
(8)
Sleep disorders (respiratory medicine)
(212)
Tobacco related disease
(19)
Tuberculosis
(54)
Rheumatology
Osteoporosis
(39)
Vascularitis
(60)
Sports and exercise medicine
(109)
Surgery
Cardiothoracic surgery
(779)
Transplantation
(203)
NON-CLINICAL
Epidemiology
Clinical trials (epidemiology)
(641)
Epidemiologic studies
(2085)
Population trends
Screening (epidemiology)
(418)
Survey techniques
Therapeutic trials
(15)
Time-to-event methods
(1)
Health informatics
Internet
(120)
Telemedicine
(8)
Health policy
(211)
Health service research
(194)
Journalology
(193)
Medical careers
Medical humanities
(10)
Medical management
Quality improvement
(32)
Occupational and environmental medicine
(147)
Patients
(165)
Public health
Air pollution
(123)
Environmental issues
(292)
Health education
(1394)
Infection control
Obesity (public health)
(226)
Screening (public health)
(418)
Smoking
(1175)
Vaccination programs
(11)
Smoking and tobacco
Cultural studies on tobacco use
Environmental tobacco smoke
Harm reduction
Health effects of tobacco use
(242)
Smokeless tobacco
Smoking cessation
(163)
Tobacco use
(1178)
Tobacco use (youth)
(215)
Statistics and research methods
Randomized controlled trials
Systematic reviews (incl meta-analyses)
Special collections
Airwaves
(8)
Editor's choice
(132)
Guidelines, Recommendations and Consensus Statements
(2)
Open access
(486)
Press releases
(52)
Thorax Images in Thorax
(240)